Pharmainfo.net
  • Home
  • Info Zone
  • Community
  • Articles
  • e-journal
  • Contact
  • My Page
Home

Third Compound From Albany Molecular Research, Inc. And Bristol-Myers Squibb Co. Selected For Preclinical Development

  • Bristol -Myers Squibb News
  • Pharma Industry News

Third Compound From Albany Molecular Research, Inc. And Bristol-Myers Squibb Co. Selected For Preclinical Development

Reuters Key Development - 1 hour ago

  • 27 reads
  • Feed: News for Bristol Myers Squibb Co. - Google Finance
  • Original article

Pharmaceutical Company News

Abbott News
AstraZeneca News
Aurobindo news
Biotechnology news
Biovail news
Boehringer Ingelheim News
Bristol -Myers Squibb News
Campus News
Caraco news
CDER News
Cipla News
CVS news
Dr.Reddy's news
FDA Drug Shortages
FDA MedWatch
FDA News
FDA Recalls
Generic drug news
GSK news
Johnson & Johnson News
Medical Device Approvals
Merck news
Mylan news
Novartis news
Novo Nordisk news
Patheon news
Pfizer news
Pharma Industry News
Pharmacy News
Ranbaxy news
Regulatory and Drug Approvals News
Rite Aid news
Roche news
Takeda news
Taro news
Teva Pharma News
Walgreens news
Watson news

Quick Links

  • Contests (PharmaGlow)
  • PPPC-03
  • Pharmacy Colleges
  • Blogs
  • PharmaTV
Copyright © 2005 - 2009 Pharmainfo.net.